Literature DB >> 1465456

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

G R Screaton1, M V Bell, D G Jackson, F B Cornelis, U Gerth, J I Bell.   

Abstract

The CD44 molecule is known to display extensive size heterogeneity, which has been attributed both to alternative splicing and to differential glycosylation within the extracellular domain. Although the presence of several alternative exons has been partly inferred from cDNA sequencing, the precise intron-exon organization of the CD44 gene has not been described to date to our knowledge. In the present study we describe the structure of the human CD44 gene, which contains at least 19 exons spanning some 50 kilobases of DNA. We have identified 10 alternatively spliced exons within the extracellular domain, including 1 exon that has not been previously reported. In addition to the inclusion or exclusion of whole exons, more diversity is generated through the utilization of internal splice donor and acceptor sites within 2 of the individual exons. The variation previously reported for the cytoplasmic domain is shown to result from the alternative splicing of 2 exons. The genomic structure of CD44 reveals a remarkable degree of complexity, and we confirm the role of alternative splicing as the basis of the structural and functional diversity seen in the CD44 molecule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465456      PMCID: PMC50718          DOI: 10.1073/pnas.89.24.12160

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  The cDNA sequence of mouse Pgp-1 and homology to human CD44 cell surface antigen and proteoglycan core/link proteins.

Authors:  E J Wolffe; W C Gause; C M Pelfrey; S M Holland; A D Steinberg; J T August
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

2.  Improved double-stranded DNA sequencing using the linear polymerase chain reaction.

Authors:  V Murray
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

3.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man.

Authors:  S T Jalkanen; R F Bargatze; L R Herron; E C Butcher
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

4.  A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins.

Authors:  L A Goldstein; D F Zhou; L J Picker; C N Minty; R F Bargatze; J F Ding; E C Butcher
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

5.  Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway.

Authors:  G Koopman; Y van Kooyk; M de Graaff; C J Meyer; C G Figdor; S T Pals
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

Review 6.  Sex in flies: the splice of life.

Authors:  B S Baker
Journal:  Nature       Date:  1989-08-17       Impact factor: 49.962

7.  Expression of CD44 is repressed in neuroblastoma cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

8.  Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor.

Authors:  D F Zhou; J F Ding; L J Picker; R F Bargatze; E C Butcher; D V Goeddel
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

9.  Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.

Authors:  G J Dougherty; P M Landorp; D L Cooper; R K Humphries
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages.

Authors:  R L Camp; T A Kraus; E Puré
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  256 in total

1.  The expression and clinical significance of CD44v in human gastric cancers.

Authors:  Guo-Yu Chen; Dao-Rong Wang
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers.

Authors:  G Woerfel; A Bindereif
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

3.  The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5' splice site.

Authors:  F Del Gatto-Konczak; C F Bourgeois; C Le Guiner; L Kister; M C Gesnel; J Stévenin; R Breathnach
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 4.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

5.  Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines.

Authors:  Anjali Shiras; Arti Bhosale; Anjali Patekar; Varsha Shepal; Padma Shastry
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72.

Authors:  Arnd Hönig; Didier Auboeuf; Marjorie M Parker; Bert W O'Malley; Susan M Berget
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

7.  Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma.

Authors:  T Nozoe; S Kohnoe; T Ezaki; A Kabashima; Y Maehara
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-11       Impact factor: 4.553

Review 8.  Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.

Authors:  Alexander Zarbock; Klaus Ley; Rodger P McEver; Andrés Hidalgo
Journal:  Blood       Date:  2011-10-20       Impact factor: 22.113

9.  Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element.

Authors:  Karl E Miletti-González; Kyle Murphy; Muthu N Kumaran; Abhilash K Ravindranath; Roman P Wernyj; Swayamjot Kaur; Gregory D Miles; Elaine Lim; Rigel Chan; Marina Chekmareva; Debra S Heller; David Foran; Wenjin Chen; Michael Reiss; Elisa V Bandera; Kathleen Scotto; Lorna Rodríguez-Rodríguez
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 10.  Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions.

Authors:  Lilly Y W Bourguignon
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.